Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction. Clinically, this may affect any of the skeletal muscles causing variable weakness, which worsens with continued muscle activity. Ocular myasthenia gravis (OMG) may affect the levator palpebrae superioris, extraocular muscles, and orbicularis oculi causing ptosis and diplopia. Meanwhile, generalized myasthenia gravis (GMG) refers to involvement of the non-ocular skeletal muscles. This talk will focus on treatment strategies for OMG. Discussion of the diagnosis of OMG and the treatment of GMG is beyond the scope.
Date
2019-03
Language
eng
Format
video/mp4
Source
2019 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of
NANOS Annual Meeting 2019: Hot Topics: How Do I Treat?
